🔴 Damora Therapeutics is trading 10.11% down today as Treasury yields approached 5%

Damora Therapeutics is trading 10.11% down now at $25.52 amid broad market risk-off pressure.

• Major U.S. indexes declined as Treasury yields approached 5%, oil prices rose, and investors positioned ahead of the Federal Reserve decision.
• No clear company-specific announcement was identified on September 15, 2026; the latest disclosure was a September 3 inducement-grant announcement.
• Healthcare sector strength does not explain the decline, which appears primarily macro-driven rather than company-specific.